Amphastar Pharmaceuticals, Inc. (FRA:29A)
21.27
-0.01 (-0.05%)
At close: Jan 30, 2026
Amphastar Pharmaceuticals Market Cap
Amphastar Pharmaceuticals has a market cap or net worth of €1.02 billion as of January 30, 2026. Its market cap has decreased by -39.50% in one year.
Market Cap
1.02B
Enterprise Value
1.34B
Revenue
616.47M
Ranking
n/a
PE Ratio
10.77
Stock Price
€21.27
Market Cap Chart
Since June 26, 2014, Amphastar Pharmaceuticals's market cap has increased from 319.81M to 1.02B, an increase of 220.37%. That is a compound annual growth rate of 10.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.02B | -2.24% |
| Dec 31, 2025 | 1.05B | -39.22% |
| Dec 31, 2024 | 1.72B | -35.67% |
| Dec 29, 2023 | 2.68B | 111.55% |
| Dec 30, 2022 | 1.27B | 29.32% |
| Dec 31, 2021 | 979.90M | 25.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |
| Maschinenfabrik Berthold Hermle AG | 787.50M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 688.26M |